A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397

By Ozaki S.   Kawamoto H.   Itoh Y.   Miyaji M.   Iwasawa Y.   Ohta H.  

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 17-18

Elsevier

Access to resources Recommend Favorite

In Vivo Pharmacological Characterisation of Bilastine, a Potent and Selective Histamine H 1 Receptor Antagonist

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustín   Orjales Aurelio  

Drugs in R&D, Vol. 7, Iss. 4, 2006-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

A water-soluble, stable dipeptide NK 1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523

By Bonnet J.   Kucharczyk N.   Robineau P.   Lonchampt M.   Dacquet C.   Regoli D.   Fauchere J.-L.   Canet E.  

European Journal of Pharmacology, Vol. 310, Iss. 1, 1996-08 ,pp. : 37-46

Elsevier

Access to resources Recommend Favorite

In vitro pharmacological characterization of a new selective angiotensin AT 1 receptor antagonist, UR-7280

By De Arriba A.F.   Gomez-Casajus L.A.   Cavalcanti F.   Almansa C.   Garcia-Rafanell J.   Forn J.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 341-347

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of T-0632, a novel potent and selective CCK A receptor antagonist, in vivo

By Taniguchi H.   Yazaki N.   Yomota E.   Shikano T.   Endo T.   Nagasaki M.  

European Journal of Pharmacology, Vol. 312, Iss. 2, 1996-09 ,pp. : 227-233

Elsevier

Access to resources Recommend Favorite